News
Media
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

Benjamin Diamond, MD

Articles by Benjamin Diamond, MD

Benjamin Diamond, MD, of Memorial Sloan Kettering Cancer Center

Dr. Diamond on the Need to Integrate MRD Testing Into Clinical Trials in Multiple Myeloma

ByBenjamin Diamond, MD

May 21st 2021

Benjamin Diamond, MD, discusses the need to integrate minimal residual disease testing into clinical trials in multiple myeloma.

Benjamin Diamond, MD, discusses the rationale for examining long-term minimal residual disease in patients with multiple myeloma.

Dr. Diamond on the Rationale for Examining Long-Term MRD in Myeloma

ByBenjamin Diamond, MD

May 5th 2021

Benjamin Diamond, MD, discusses the rationale for examining long-term minimal residual disease in patients with multiple myeloma.

Latest Updated Articles

Dr. Diamond on the Rationale for Examining Long-Term MRD in Myeloma
May 5th 2021
Dr. Diamond on the Need to Integrate MRD Testing Into Clinical Trials in Multiple Myeloma
May 21st 2021

Trending on OncLive

FDA Approves Zidesamtinib in Pretreated ROS1+ NSCLC

Ivonescimab Plus Chemotherapy Sustains OS Benefit Across Western and Asian Patients in Pretreated EGFR-Mutated NSCLC

NMPA Accepts Toripalimab Plus Chemotherapy Application for Expanded Stage II-III NSCLC Use

Dr Patel on the Unmet Need in EGFR+ Transformed Small Cell Lung Cancer

Dr Hoffmann on the Significance of Efficacy Data for Sonrotoclax Plus Zanubrutinib in MCL